Brief: Nextcell Signs Agreement For New Tissue Product
10/10/2023 13:32
Oct 10 (Reuters) - NextCell Pharma AB NXTCL.ST :
* NEXTCELL SIGNS AN AGREEMENT FOR A NEW TISSUE PRODUCT
* VALUE OF AGREEMENT FOR FIRST YEAR AMOUNTS TO APPROXIMATELY
400
000 SEK
Source text for Eikon: ID:nWkr1qksq6
Further company coverage: NXTCL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
Brief: NextCell Board Proposes Directed Issue Of 15,000,000 Shares
Brief: Nextcell Decides To Propose Directed Share Issue Of SEK 15 Mln